Full squad lists, as they are announced, for the 2025 Champions Trophy. Female cricketers from Afghanistan are to become the first recipients of support from a Global Refugee Cricket Fund ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...

The Milton Keynes resident is a former athlete who represented Italy in track competitions. The investigation comes after Italian authorities freed a Libyan national wanted by the ICC. Italian ...

Image: Was the right decision made not to send off David Brooks [left] after his clash with Marc Cucurella at Stamford Bridge on Tuesday? Ex-top flight referee Dermot Gallagher assesses the ...

Last year was a big year for Fairbanks Museum, highlighted by major moments in the museum’s 136-year history, but in 2025, the museum will focus on the smaller things, both literally and ...

Vito Coppola has revealed he's set to miss out on the start of the Strictly Come Dancing Live tour as he has been hit with an injury blow. The professional dancer recently excitedly revealed that ...

President Donald Trump talks to the media at a public press event following the RNC debate in Houston, Texas in February 2016. Picture: Stock_photo_world/Shutterstock ...

The investigational oral therapies DNL343 and fosigotifator didn’t significantly slow disease progression in people with amyotrophic lateral sclerosis (ALS) compared with a placebo, and therefore ...

The experimental drug, fosigotifator, was tested as a potential treatment for amyotrophic lateral sclerosis (ALS). This deadly neurodegenerative disease affects the nerve cells in the brain and ...

The Californian firm has revealed disappointing initial top-line results from Regimen F of the HEALEY ALS Platform Trial evaluating fosigotifator (ABBV-CLS-7262) in adults with amyotrophic lateral ...

Researchers at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital said fosigotifator, the investigational drug being developed by Calico Life Sciences in collaboration with ...

Massachusetts General Hospital found neither AbbVie and Calico’s fosigotifator nor Denali’s DNL343 significantly slowed disease progression, causing misses on their respective primary endpoints.